| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060019922 Selective killing of cancerous cells |
| 01/26/2006 | US20060019918 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 01/26/2006 | US20060019916 Immunostimulatory nucleic acids for inducing IL-10 responses |
| 01/26/2006 | US20060019912 Cell transfecting formulations of small interfering RNA related compositions and methods of making and use |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019888 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors |
| 01/26/2006 | US20060019886 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 01/26/2006 | US20060019885 Modified bryodin 1 with reduced immunogenicity |
| 01/26/2006 | US20060019881 Human spasmolytic polypeptide in glycosylated form |
| 01/26/2006 | US20060019877 Hasylated polypeptides |
| 01/26/2006 | US20060019396 Retroviral vectors with enhanced efficiency of transgene expression and safety |
| 01/26/2006 | US20060019395 Lentiviral vectors and uses thereof |
| 01/26/2006 | US20060019394 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 01/26/2006 | US20060019393 Minimal lentiviral vector system |
| 01/26/2006 | US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems |
| 01/26/2006 | US20060019384 Susceptible to baculovirus infection, useful for replicating, for gene expression using a baculovirus expression system |
| 01/26/2006 | US20060019383 Chemical inhibitors of mismatch repair |
| 01/26/2006 | US20060019382 Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors |
| 01/26/2006 | US20060019381 comprises heat shock proteins LINKED TO POLYNUCLEOTIDE ENCODING HIV-TAT TRANSACTIVATING FACTOR, WHICH ACTIVATES HIV-2 PROMOTER |
| 01/26/2006 | US20060019380 Genetic vaccines directed against bacterial exotoxins |
| 01/26/2006 | US20060019371 Macrolide analogs |
| 01/26/2006 | US20060019370 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 01/26/2006 | US20060019369 for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion |
| 01/26/2006 | US20060019368 Constructs for homogenously processed preparations of beta site APP-cleaving enzyme |
| 01/26/2006 | US20060019367 a neutral Streptoverticillium mobaraense metalloprotease from actinomycetes which selectively cleaves a pro-structure part of a microbial protransglutaminase |
| 01/26/2006 | US20060019365 IKK-alpha proteins, nucleic acids and methods |
| 01/26/2006 | US20060019357 Nucleotide sequences which code for the rpsL gene |
| 01/26/2006 | US20060019356 Polynucleotides encoding polypeptides involved in intermediates metabolism of the central metabolic pathway in Methylophilus methylotrophus |
| 01/26/2006 | US20060019354 Nucleic acid sequences used to generate bacteria that hyper-produce exopolysaccharide in slime form; Sphingomonas |
| 01/26/2006 | US20060019353 Protein-nucleic acid conjugate for producing specific nucleic acid |
| 01/26/2006 | US20060019352 Methods of increasing the production of cobalamins using cob gene expression |
| 01/26/2006 | US20060019351 Enhanced secretion of a polypeptide by a microorganism |
| 01/26/2006 | US20060019350 Recombinant negative strand RNA virus expression system and vacccines |
| 01/26/2006 | US20060019349 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 01/26/2006 | US20060019348 Method of mass producing silk protein and gene recombinant silk-like protein with added functionality |
| 01/26/2006 | US20060019345 Human GABAb receptor 1 promoters |
| 01/26/2006 | US20060019344 C-erbB-2 external domain: gp75 |
| 01/26/2006 | US20060019343 Pichia methanolica secretory signal |
| 01/26/2006 | US20060019341 Aminopeptidase |
| 01/26/2006 | US20060019337 Dual expression vector system and screening methods |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019328 Glucose dehydrogenase |
| 01/26/2006 | US20060019324 PknB kinase and pstP phosphatase and methods of identifying inhibitory substances |
| 01/26/2006 | US20060019318 Conformational and topological protein regulation |
| 01/26/2006 | US20060019316 Apparatus and method for automated protein design |
| 01/26/2006 | US20060019306 Use of a gene expressed by fungal cells producing ochratoxin A in the detection and/or identification of ochratoxigenic fungi; Aspergillus ochraceus |
| 01/26/2006 | US20060019300 Method for in vitro molecular evolution of protein function |
| 01/26/2006 | US20060019297 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019293 Mutations of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 01/26/2006 | US20060019292 Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same |
| 01/26/2006 | US20060019291 Cloning system for construction of recombinant expression vectors |
| 01/26/2006 | US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/26/2006 | US20060019281 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
| 01/26/2006 | US20060019277 Digital amplification for detection of mismatch repair deficient tumor cells |
| 01/26/2006 | US20060019275 Nucleic acids encoding proteins involved in sensory transduction |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060019257 Compositions and methods for increasing protein production |
| 01/26/2006 | US20060019252 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 01/26/2006 | US20060019245 HCV variants |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060019238 Method for identifying protein-protein interactions |
| 01/26/2006 | US20060018971 Nucleic acid microspheres, production and delivery thereof |
| 01/26/2006 | US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1 |
| 01/26/2006 | US20060018930 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/26/2006 | US20060018928 Virus-like particle containing a dengue virus recombinant replicon |
| 01/26/2006 | US20060018924 Recombinantly produced, enzymatically active, includes two amino acid motifs |
| 01/26/2006 | US20060018923 A nucleotide sequence along with the deduced amino acid sequences of the complete genomic sequence of a novel human coronavirus (CoV-HKU1) of the order Nidovirales; single-stranded RNA virus of positive polarity; immunogenic/vaccine preparations using recombinant and chimeric forms; vectors; cells |
| 01/26/2006 | US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| 01/26/2006 | US20060018917 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 01/26/2006 | US20060018916 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018914 Novel antibody conjugates reactive with human carcinomas |
| 01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 01/26/2006 | US20060018900 Self antigen vaccines for treating B-cell lymphomas and other cancers |
| 01/26/2006 | US20060018898 Antibody variants |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018893 Method for determining modulation of P110delta activity |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018888 Suicidal mutant leishmania vaccine |
| 01/26/2006 | US20060018884 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018880 Methods and compositions for delivery of an enhanced response to antigenic substrates |
| 01/26/2006 | US20060018879 Expression vectors for treating bacterial infections |
| 01/26/2006 | US20060018878 Dual antigen specific T cells with trafficking ability |
| 01/26/2006 | US20060018871 aptamer PEG conjugate; transplant rejection; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 01/26/2006 | US20060018859 Modified human serum albumin with reduced or eliminated affinity to chemical or biological contaminants at Cys 34 |
| 01/26/2006 | US20060018841 AAV vectors for gene delivery to the lung |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | DE10393660T5 Verfahren zur Identifizierung von Protein-CAMs (konstitutiv aktive Mutanten) A method of identifying protein CAMs (constitutively active mutants) |
| 01/26/2006 | DE102004032216A1 Polypeptide mit Tannase- und/oder Lipase-Aktivität Polypeptides with Tannase- and / or lipase activity |
| 01/26/2006 | DE102004030608A1 Verfahren zur Erhöhung der Pathogenresistenz in transgenen Pflanzen durch Expression einer Peroxidase Method for increasing the pathogen resistance in transgenic plants by expression of a peroxidase |
| 01/26/2006 | DE102004024184A1 Neue Nukleinsäuresequenzen und deren Verwendung in Verfahren zum Erreichen einer Pathogenresistenz in Pflanzen New nucleic acid sequences and to their use in methods for obtaining a pathogen resistance in plants |
| 01/26/2006 | CA2856001A1 Plant galactinol synthase homologs |
| 01/26/2006 | CA2847655A1 Brassica indehiscent1 sequences |
| 01/26/2006 | CA2612303A1 Anti-glycated cd59 antibodies and uses thereof |
| 01/26/2006 | CA2574530A1 Cell cycle phase markers comprising phosphorylated subcellular localization domain (psld) of human dna helicase b (hdhb) |
| 01/26/2006 | CA2574179A1 Detection of cellular stress |
| 01/26/2006 | CA2574177A1 Lrp4/corin dopaminergic neuron progenitor cell markers |